Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29039493)

  • 1. Actein induces apoptosis in leukemia cells through suppressing RhoA/ROCK1 signaling pathway.
    Zhou WD; Wang X; Sun XZ; Hu J; Zhang RR; Hong Z
    Int J Oncol; 2017 Dec; 51(6):1831-1841. PubMed ID: 29039493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoA/ROCK/PTEN signaling is involved in AT-101-mediated apoptosis in human leukemia cells in vitro and in vivo.
    Li G; Liu L; Shan C; Cheng Q; Budhraja A; Zhou T; Cui H; Gao N
    Cell Death Dis; 2014 Jan; 5(1):e998. PubMed ID: 24434521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyclohexene derivative MC-3129 exhibits antileukemic activity via RhoA/ROCK1/PTEN/PI3K/Akt pathway-mediated mitochondrial translocation of cofilin.
    Zheng Y; Ouyang Q; Fu R; Liu L; Zhang H; Hu X; Liu Y; Chen Y; Gao N
    Cell Death Dis; 2018 May; 9(6):656. PubMed ID: 29844397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dephosphorylation and mitochondrial translocation of cofilin sensitizes human leukemia cells to cerulenin-induced apoptosis via the ROCK1/Akt/JNK signaling pathway.
    Zhang Y; Fu R; Liu Y; Li J; Zhang H; Hu X; Chen Y; Liu X; Li Y; Li P; Liu E; Gao N
    Oncotarget; 2016 Apr; 7(15):20655-68. PubMed ID: 26967395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actein inhibits glioma growth via a mitochondria-mediated pathway.
    Yuan LQ; Chen YM; Sun C; Wang ZY; Wang DL; Lan Q
    Cancer Biomark; 2017; 18(4):329-338. PubMed ID: 28128733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo.
    Budhraja A; Gao N; Zhang Z; Son YO; Cheng S; Wang X; Ding S; Hitron A; Chen G; Luo J; Shi X
    Mol Cancer Ther; 2012 Jan; 11(1):132-42. PubMed ID: 22084167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptolide induces apoptosis in human leukemia cells through caspase-3-mediated ROCK1 activation and MLC phosphorylation.
    Liu L; Li G; Li Q; Jin Z; Zhang L; Zhou J; Hu X; Zhou T; Chen J; Gao N
    Cell Death Dis; 2013 Dec; 4(12):e941. PubMed ID: 24309928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corchorusin-D directed apoptosis of K562 cells occurs through activation of mitochondrial and death receptor pathways and suppression of AKT/PKB pathway.
    Mallick S; Pal BC; Vedasiromoni JR; Kumar D; Saha KD
    Cell Physiol Biochem; 2012; 30(4):915-26. PubMed ID: 22965801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in Vitro and in Vivo Antitumor Activities of Tetracyclic Triterpenoids Compounds Actein and 26-Deoxyactein Isolated from Rhizome of Cimicifuga foetida L.
    Wu D; Yao Q; Chen Y; Hu X; Qing C; Qiu M
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron oxide magnetic nanoparticles combined with actein suppress non-small-cell lung cancer growth in a p53-dependent manner.
    Wang MS; Chen L; Xiong YQ; Xu J; Wang JP; Meng ZL
    Int J Nanomedicine; 2017; 12():7627-7651. PubMed ID: 29089760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actein antagonizes colorectal cancer through blocking PI3K/Akt pathways by downregulating IMPDH2.
    Yan L; Wang D; Liu X; Gu C; Gao S
    Anticancer Drugs; 2021 Sep; 32(8):864-874. PubMed ID: 33929996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actein enhances TRAIL effects on suppressing gastric cancer progression by activating p53/Caspase-3 signaling.
    Yang ZC; Ma J
    Biochem Biophys Res Commun; 2018 Mar; 497(4):1177-1183. PubMed ID: 27914809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actein Antagonizes Oral Squamous Cell Carcinoma Proliferation through Activating FoxO1.
    Zhao C; Zhang Z; Dai X; Wang J; Liu H; Ma H
    Pharmacology; 2021; 106(9-10):551-563. PubMed ID: 34175854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphenols isolated from Allium cepa L. induces apoptosis by suppressing IAP-1 through inhibiting PI3K/Akt signaling pathways in human leukemic cells.
    Han MH; Lee WS; Jung JH; Jeong JH; Park C; Kim HJ; Kim G; Jung JM; Kwon TK; Kim GY; Ryu CH; Shin SC; Hong SC; Choi YH
    Food Chem Toxicol; 2013 Dec; 62():382-9. PubMed ID: 24021570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoA modulates functional and physical interaction between ROCK1 and Erk1/2 in selenite-induced apoptosis of leukaemia cells.
    Li F; Jiang Q; Shi KJ; Luo H; Yang Y; Xu CM
    Cell Death Dis; 2013 Jul; 4(7):e708. PubMed ID: 23828571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species.
    Rahmani M; Reese E; Dai Y; Bauer C; Payne SG; Dent P; Spiegel S; Grant S
    Cancer Res; 2005 Mar; 65(6):2422-32. PubMed ID: 15781658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringenin-induced apoptosis is attenuated by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human leukemia U937 cells.
    Jin CY; Park C; Lee JH; Chung KT; Kwon TK; Kim GY; Choi BT; Choi YH
    Toxicol In Vitro; 2009 Mar; 23(2):259-65. PubMed ID: 19124070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial translocation of cofilin is required for allyl isothiocyanate-mediated cell death via ROCK1/PTEN/PI3K signaling pathway.
    Li GB; Cheng Q; Liu L; Zhou T; Shan CY; Hu XY; Zhou J; Liu EH; Li P; Gao N
    Cell Commun Signal; 2013 Jul; 11():50. PubMed ID: 23895248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
    Rosato RR; Almenara JA; Coe S; Grant S
    Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursolic acid induces apoptosis in human leukaemia cells and exhibits anti-leukaemic activity in nude mice through the PKB pathway.
    Gao N; Cheng S; Budhraja A; Gao Z; Chen J; Liu EH; Huang C; Chen D; Yang Z; Liu Q; Li P; Shi X; Zhang Z
    Br J Pharmacol; 2012 Mar; 165(6):1813-1826. PubMed ID: 21950524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.